- Home
- CERS vs NEN Comparison
CERS vs NEN Comparison
Compare CERS & NEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CERS
- NEN
- Stock Information
- Founded
- CERS 1991
- NEN 1977
- Country
- CERS United States
- NEN United States
- Employees
- CERS N/A
- NEN N/A
- Industry
- CERS EDP Services
- NEN Building operators
- Sector
- CERS Technology
- NEN Real Estate
- Exchange
- CERS Nasdaq
- NEN Nasdaq
- Market Cap
- CERS 255.0M
- NEN 262.4M
- IPO Year
- CERS 1997
- NEN N/A
- Fundamental
- Price
- CERS $1.30
- NEN $72.00
- Analyst Decision
- CERS Strong Buy
- NEN
- Analyst Count
- CERS 2
- NEN 0
- Target Price
- CERS $3.50
- NEN N/A
- AVG Volume (30 Days)
- CERS 1.2M
- NEN 380.0
- Earning Date
- CERS 10-29-2025
- NEN 01-01-0001
- Dividend Yield
- CERS N/A
- NEN 6.59%
- EPS Growth
- CERS N/A
- NEN 34.86
- EPS
- CERS N/A
- NEN 4.59
- Revenue
- CERS $192,510,000.00
- NEN $83,884,808.00
- Revenue This Year
- CERS $30.03
- NEN N/A
- Revenue Next Year
- CERS $9.37
- NEN N/A
- P/E Ratio
- CERS N/A
- NEN $15.69
- Revenue Growth
- CERS 13.25
- NEN 4.96
- 52 Week Low
- CERS $1.12
- NEN $71.00
- 52 Week High
- CERS $2.24
- NEN $84.00
- Technical
- Relative Strength Index (RSI)
- CERS 50.21
- NEN 50.10
- Support Level
- CERS $1.26
- NEN $71.00
- Resistance Level
- CERS $1.35
- NEN $72.00
- Average True Range (ATR)
- CERS 0.07
- NEN 0.08
- MACD
- CERS 0.01
- NEN 0.16
- Stochastic Oscillator
- CERS 51.72
- NEN 100.00
About CERS Cerus Corporation
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.
About NEN New England Realty Associates Limited Partnership Depositary Receipts Evidencing Units of Limited Partnership
New England Realty Associates LP is engaged in the business of acquiring, developing, holding for investment, operating and selling real estate. The Partnership owns and operates various residential apartments, condominium units and commercial properties located in Massachusetts and New Hampshire. The company generates revenue from rental income from residential and commercial properties recognized over the term of the related lease. The long-term goals of the Partnership are to manage, rent and improve its properties and to acquire additional properties with income and capital appreciation potential as suitable opportunities arise.